Trial Profile
Phase II Trial of STI571 in Patients With Relapsed Small Cell Lung Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 18 Sep 2005 New trial record.